TRICYCLIC COMPOUNDS AS INHIBITORS OF NLRP3
The invention relates to novel compounds for use as inhibitors of NLRP3 inflammasone production, wherein such compounds are as defined by compounds of formula (I) and wherein the integers R1, R2 and R3 are defined in the description, and where the compounds may be useful as medicaments, for instance...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | VAN OPDENBOSCH, Nina DIÉGUEZ-VÁZQUEZ, Alejandro OEHLRICH, Daniel LAMKANFI, Mohamed VAN GOOL, Michiel Luc Maria CAÑELLAS ROMAN, Santiago |
| description | The invention relates to novel compounds for use as inhibitors of NLRP3 inflammasone production, wherein such compounds are as defined by compounds of formula (I) and wherein the integers R1, R2 and R3 are defined in the description, and where the compounds may be useful as medicaments, for instance for use in the treatment of a disease or disorder that is associated with NLRP3 inflammasome activity. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2023203064A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2023203064A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2023203064A13</originalsourceid><addsrcrecordid>eNrjZNAKCfJ0jnT28XRWcPb3DfAP9XMJVnAMVvD08_B08gzxDwpW8HdT8PMJCjDmYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXxocFGBkbGRgbGBmYmjobGxKkCAOYxJYI</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>TRICYCLIC COMPOUNDS AS INHIBITORS OF NLRP3</title><source>esp@cenet</source><creator>VAN OPDENBOSCH, Nina ; DIÉGUEZ-VÁZQUEZ, Alejandro ; OEHLRICH, Daniel ; LAMKANFI, Mohamed ; VAN GOOL, Michiel Luc Maria ; CAÑELLAS ROMAN, Santiago</creator><creatorcontrib>VAN OPDENBOSCH, Nina ; DIÉGUEZ-VÁZQUEZ, Alejandro ; OEHLRICH, Daniel ; LAMKANFI, Mohamed ; VAN GOOL, Michiel Luc Maria ; CAÑELLAS ROMAN, Santiago</creatorcontrib><description>The invention relates to novel compounds for use as inhibitors of NLRP3 inflammasone production, wherein such compounds are as defined by compounds of formula (I) and wherein the integers R1, R2 and R3 are defined in the description, and where the compounds may be useful as medicaments, for instance for use in the treatment of a disease or disorder that is associated with NLRP3 inflammasome activity.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; METALLURGY ; ORGANIC CHEMISTRY</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230629&DB=EPODOC&CC=US&NR=2023203064A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76294</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230629&DB=EPODOC&CC=US&NR=2023203064A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>VAN OPDENBOSCH, Nina</creatorcontrib><creatorcontrib>DIÉGUEZ-VÁZQUEZ, Alejandro</creatorcontrib><creatorcontrib>OEHLRICH, Daniel</creatorcontrib><creatorcontrib>LAMKANFI, Mohamed</creatorcontrib><creatorcontrib>VAN GOOL, Michiel Luc Maria</creatorcontrib><creatorcontrib>CAÑELLAS ROMAN, Santiago</creatorcontrib><title>TRICYCLIC COMPOUNDS AS INHIBITORS OF NLRP3</title><description>The invention relates to novel compounds for use as inhibitors of NLRP3 inflammasone production, wherein such compounds are as defined by compounds of formula (I) and wherein the integers R1, R2 and R3 are defined in the description, and where the compounds may be useful as medicaments, for instance for use in the treatment of a disease or disorder that is associated with NLRP3 inflammasome activity.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNAKCfJ0jnT28XRWcPb3DfAP9XMJVnAMVvD08_B08gzxDwpW8HdT8PMJCjDmYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXxocFGBkbGRgbGBmYmjobGxKkCAOYxJYI</recordid><startdate>20230629</startdate><enddate>20230629</enddate><creator>VAN OPDENBOSCH, Nina</creator><creator>DIÉGUEZ-VÁZQUEZ, Alejandro</creator><creator>OEHLRICH, Daniel</creator><creator>LAMKANFI, Mohamed</creator><creator>VAN GOOL, Michiel Luc Maria</creator><creator>CAÑELLAS ROMAN, Santiago</creator><scope>EVB</scope></search><sort><creationdate>20230629</creationdate><title>TRICYCLIC COMPOUNDS AS INHIBITORS OF NLRP3</title><author>VAN OPDENBOSCH, Nina ; DIÉGUEZ-VÁZQUEZ, Alejandro ; OEHLRICH, Daniel ; LAMKANFI, Mohamed ; VAN GOOL, Michiel Luc Maria ; CAÑELLAS ROMAN, Santiago</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2023203064A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2023</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><toplevel>online_resources</toplevel><creatorcontrib>VAN OPDENBOSCH, Nina</creatorcontrib><creatorcontrib>DIÉGUEZ-VÁZQUEZ, Alejandro</creatorcontrib><creatorcontrib>OEHLRICH, Daniel</creatorcontrib><creatorcontrib>LAMKANFI, Mohamed</creatorcontrib><creatorcontrib>VAN GOOL, Michiel Luc Maria</creatorcontrib><creatorcontrib>CAÑELLAS ROMAN, Santiago</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>VAN OPDENBOSCH, Nina</au><au>DIÉGUEZ-VÁZQUEZ, Alejandro</au><au>OEHLRICH, Daniel</au><au>LAMKANFI, Mohamed</au><au>VAN GOOL, Michiel Luc Maria</au><au>CAÑELLAS ROMAN, Santiago</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>TRICYCLIC COMPOUNDS AS INHIBITORS OF NLRP3</title><date>2023-06-29</date><risdate>2023</risdate><abstract>The invention relates to novel compounds for use as inhibitors of NLRP3 inflammasone production, wherein such compounds are as defined by compounds of formula (I) and wherein the integers R1, R2 and R3 are defined in the description, and where the compounds may be useful as medicaments, for instance for use in the treatment of a disease or disorder that is associated with NLRP3 inflammasome activity.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_US2023203064A1 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS METALLURGY ORGANIC CHEMISTRY |
| title | TRICYCLIC COMPOUNDS AS INHIBITORS OF NLRP3 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T04%3A51%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=VAN%20OPDENBOSCH,%20Nina&rft.date=2023-06-29&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2023203064A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |